Mechanism of antifungal action of kanosamine

Medical Mycology

Volumn 39, Issue 5, 2001, Pages 401-408

  Janiak, A M ^a   Milewski, S ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Candida albicans; Chitin; Enzyme inhibition; Kanosamine

Indexed keywords

ACYLTRANSFERASE; ANTIBIOTIC AGENT; DRUG METABOLITE; FRUCTOSE 6 PHOSPHATE; GLUTAMINE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; KANOSAMINE; KANOSAMINE 6 PHOSPHATE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS; BACTERIAL GROWTH; BACTERIUM MUTANT; CANDIDA ALBICANS; CATALYSIS; CELL AGGLUTINATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG METABOLISM; DRUG TRANSPORT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; FUNGUS HYPHAE; GLUCOSE TRANSPORT SYSTEM; GROWTH INHIBITION; MORPHOLOGY; NONHUMAN; PHOSPHORYLATION; SACCHAROMYCES CEREVISIAE;

EID: 0035155243     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.39.5.401.408     Document Type: Article

References (29)

1. Kauffman CA, Carver PG. Antifungal agents in the 1990s. Current status and future developments. Drugs 1997; 53: 539549.
2. Cron MJ, Evans DL, Palermiti FM, et al. Kanamycin. V. The structure of kanosamine. J Am Chem Soc 1958; 80: 4741-4742.
3. Umezawa, S, Umino K, Shibahara S, Hamada M, Omoto S. Fermentation of 3-amino-3-deoxy-D-glucose. J Antibiot 1967; 20: 355-360.
4. Milner JL, Silo-Suh L,. Lee JC, et al. Production of kanosamine by Bacillus cereus UW85. Appl Environ Microbiol. 1996; 62: 3061-3065.
5. Iwai Y, Tanaka H, Oiwa R, Shimizu S, Omura S. Studies on bacterial cell wall inhibitors. III. 3-amino-3-deoxy-o-glucose, an inhibitor of bacterial cell wall synthesis. Biochim Biophys Acta 1977; 498: 223-228.
6. Tanaka H, Shimizu S, Oiwa R, Iwai Y, Omura S. The site of inhibition of cell wall synthesis by 3-amino-3-deoxy-D-glucose in Staphylococcus aureus. J Biochem 1979; 86: 155-159.
7. Dogra S, Krishnamurthy S, Gupta V, et al. Asymmetric distribution of phosphatidylethanolamine in C. albicans. Possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily. Yeast 1999; 15: 111121.
8. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeast: proposed standards. Document M27-A. National Committee for Clinical Laboratory Standards. Wayne, Pennsylvania, 1997.
9. Anfärbereagenzien für Dünnschicht- und Papier-Chromatographie, E. Merck, Darmstadt, 1970.
10. Milewski S, Kuszczak D, Jedrzejczak R, et al. Oligomeric structure and regulation of Candida albicans glucosamine-6phosphate synthase. J Biol Chem 1999; 274: 4000-4008.
11. Bollag DM, Edelstein SJ. Protein Methods. New York: WileyLisslnc., 1991.
12. Kenig ME, Vandamme E, Abraham EP. The mode of action of bacilysin and anticapsin and biochemical properties of bacilysinresistant mutants. J Gen Microbiol 1976; 94: 46-54
13. Davidson EA. Glucosamine 6-phosphate N-acetylase. Meth Enzymol 1966; 9: 704-707.
14. Bradford M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
15. Milewski S, Andruszkiewicz R, Kasprzak L, et al. Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase. Antimicrob Agents Chemother 1988: 35: 36-54.
16. Becker JM, Covert NL, Shenbagamurthi P, Steinfeld AS, Naider F. Polyoxin D inhibits growth of zoopathogenic fungi. Antimicrob Agents Chemother 1983; 23: 926-929.
17. Hector RF, Brown PC. Synergistic action of nikkomycins X and Z with papulacandin B on whole cells and regenerating protoplasts of Candida albicans. Antimicrob Agents Chemother 1986; 29: 389-394.
18. Vespa MN, Lebecq JC. The morphology of Candida albicans in two different Earle base media in the presence of tunicamycin. Mycoses 1996: 39: 271-277.
19. Ziegelbauer K, Babczinski P, Schonfeld W. Molecular mode of action of the antifungal β-amino acid BAY 10-8888. Antimicrob Agents Chemother 1998; 42: 2197-2205.
20. Lagunas R. Sugar transport in Saccharomyces cerevisiae. FEMS Microbiol Revl993; 10: 229-242.
21. Horak J. Yeast nutrient transporters. Biochim Biophys Acta 1997; 1331: 41-79.
22. Machado de Domenech EE, Sols A. Specifity of hexokinases towards some uncommon substrates and inhibitors. FEBS Lett 1980; 119: 174-176.
23. Badet B, Vermoote, P, Le Goffic F. Glucosamine synthetase from E.scherichia coll: kinetic mechanism and inhibition by N3fumaroyl-L-diaminopropionic derivatives. Biochemistry 1988; 27: 2282-2287.
24. Singh BR, Datta A. Induction of A'-acetylglucosamine-catabolic pathway in spheroplasts of Candida albicans. Biochem J 1979; 178:427-431.
25. Giordani R, Cardenas ML, Moulin-Traffort J, Regli P. Fungicidal activity of latex sap from Carica papaya and antifungal effect of D(+)-glucosamine on Candida albicans growth. Mycoses 1996; 39: 103-110.
26. Elliot JJ, Ball AJS. Glucosamine resistance in the yeast Saccharomyces cerevisiae. Genetics 1973; 74: S71.
27. Chmara H. Smulkowski M. Borowski E. Growth inhibitory effects of amidotransferase inhibition in Candida albicam by epoxypeptides. Drugs Exp Clin Res 1980; 6: 7-14.
28. Andruszkiewicz R. Milewski S, Zieniawa T, Borowski E. Anticandidal properties of /V3-(4-methoxyfumaroyl)-L-2,3-dia minopropanoic acid oligopeptides. J Med Chem 1990: 33: 132135.
29. Kasprzak L. Milewski S, Gumieniak J, Borowski E, The influence of serum proteins on biological activity of anticandidal peptides containing /V3-(4-methoxyfumaroyI)-L-2,3-diaminopropanoic acid. / Chemother 1992; 4: 88-94.